Analysts’ Updated EPS Estimates for November, 2nd (BSMX, CTSH, EPZM, EQIX, EVHC, FB, FORM, INGR, IPHI, JUNO)

Analysts’ updated eps estimates for Thursday, November 2nd:

Grupo Financiero Santander Mexico S.A. B. de C.V. (NYSE:BSMX) had its neutral rating reissued by analysts at J P Morgan Chase & Co.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) had its outperform rating reissued by analysts at Credit Suisse Group. The firm currently has a $89.00 target price on the stock, up from their previous target price of $80.00.

Epizyme (NASDAQ:EPZM) had its outperform rating reiterated by analysts at Leerink Swann. The firm currently has a $22.00 target price on the stock, down from their previous target price of $28.00.

Equinix (NASDAQ:EQIX) had its outperform rating reaffirmed by analysts at Credit Suisse Group. Credit Suisse Group currently has a $515.00 price target on the stock, up from their previous price target of $510.00.

Envision Healthcare Corporation (NYSE:EVHC) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $32.00 price target on the stock, down from their previous price target of $68.00.

Facebook (NASDAQ:FB) had its outperform rating reissued by analysts at Credit Suisse Group. They currently have a $230.00 price target on the stock, down from their previous price target of $235.00.

FormFactor (NASDAQ:FORM) had its buy rating reaffirmed by analysts at B. Riley. B. Riley currently has a $22.00 target price on the stock, up from their previous target price of $20.00.

Ingredion (NYSE:INGR) had its outperform rating reissued by analysts at Credit Suisse Group. Credit Suisse Group currently has a $145.00 target price on the stock, up from their previous target price of $140.00.

Inphi Corporation (NYSE:IPHI) had its buy rating reaffirmed by analysts at B. Riley. The firm currently has a $48.00 target price on the stock, up from their previous target price of $42.50.

Juno Therapeutics (NASDAQ:JUNO) had its in-line rating reaffirmed by analysts at Leerink Swann. The firm currently has a $56.00 price target on the stock, up from their previous price target of $34.00.

The Kraft Heinz (NASDAQ:KHC) had its outperform rating reiterated by analysts at Credit Suisse Group. The firm currently has a $90.00 price target on the stock, down from their previous price target of $100.00.

Lundin Petroleum AB (OTCMKTS:LNDNF) had its equal weight rating reaffirmed by analysts at Barclays PLC.

Dougherty & Co assumed coverage on shares of Medidata Solutions (NASDAQ:MDSO). The firm issued a neutral rating on the stock.

MSCI (NYSE:MSCI) had its buy rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $126.00 target price on the stock. The analysts wrote, “3Q17 revenues just above expectations. 3Q17 revenue was $322.1 mn, up 11.7% y/y (+11.9% in constant currency), vs. our estimate of $321.0 mn and the FactSet consensus of $321.7 mn. Growth was driven by continued strength in the Index product line, aided by all time highs in global ETF AuM. 3Q17 adjusted EPS was $1.00, above our estimate of $0.98 and the consensus of $0.97. Adjusted EBITDA margin was 52.3%, from 3Q16’s 49.7%, vs. our estimate of 52.7%.””

Neurocrine Biosciences (NASDAQ:NBIX) had its outperform rating reissued by analysts at Leerink Swann. Leerink Swann currently has a $83.00 target price on the stock, up from their previous target price of $72.00.

Newell Brands (NYSE:NWL) had its hold rating reissued by analysts at Jefferies Group LLC. They currently have a $47.00 price target on the stock. The analysts wrote, “NWL reported very disappointing 3Q results, incl. lower than expected core sales (+0.4% vs. +1.5-2.5%/2.9% mkt/Street), margins, EPS ($0.86, or $0.81 ex-tax rate vs. our model w/Street $0.92), and CFFO. FY17 guidance revised lower for core sales (1.5-2% vs. 2.5-4% prior) and EPS ($2.80-$2.85 vs. $2.95- $3.05 prior).””

NexPoint Residential Trust (NASDAQ:NXRT) had its buy rating reaffirmed by analysts at B. Riley. They currently have a $28.00 price target on the stock, up from their previous price target of $27.00.

Owens & Minor (NYSE:OMI) had its market perform rating reaffirmed by analysts at Leerink Swann. They currently have a $23.00 price target on the stock, down from their previous price target of $34.00.

Paddy Power Plc (LON:PAP) had its hold rating reissued by analysts at Numis Securities Ltd. They currently have a GBX 8,000 ($105.57) price target on the stock.

Progenics Pharmaceuticals (NASDAQ:PGNX) had its buy rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $15.00 target price on the stock. The analysts wrote, “PGNX has completed the rolling NDA for AZEDRA for pheochromocytoma and paraganglioma.””

IMPINJ (NYSE:PI) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $35.00 target price on the stock, down from their previous target price of $50.00.

IMPINJ (NYSE:PI) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $34.00 target price on the stock.

Shopify (NYSE:SHOP) (TSE:SH) had its outperform rating reissued by analysts at Wedbush. They currently have a $120.00 target price on the stock.

Spire Corp. (OTCMKTS:SPIR) had its outperform rating reiterated by analysts at Credit Suisse Group. Credit Suisse Group currently has a $97.00 target price on the stock, up from their previous target price of $88.00. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Spirit Aerosystems Holdings (NYSE:SPR) had its in-line rating reiterated by analysts at Sanford C. Bernstein. The firm currently has a $98.00 price target on the stock, up from their previous price target of $87.00.

Stratasys (NASDAQ:SSYS) had its neutral rating reissued by analysts at B. Riley. The firm currently has a $30.00 price target on the stock, down from their previous price target of $33.00.

The Ultimate Software Group (NASDAQ:ULTI) had its outperform rating reaffirmed by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $240.00 target price on the stock, up from their previous target price of $230.00.

Yelp (NYSE:YELP) had its market perform rating reiterated by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $45.00 price target on the stock, up from their previous price target of $36.00. The analysts wrote, “We See Limited Upside, 3/2/17, we believe a full transition to a dynamic lead generation monetization model (the ideal format, in our view) will require substantial changes to Yelp’s current RAQ model. Further, we question what we view as bullish investor assumptions that development of a lead generation model will necessarily be additive to Yelp’s ad revenue growth profile.””

Zendesk (NYSE:ZEN) had its outperform rating reaffirmed by analysts at Wells Fargo & Company. The firm currently has a $40.00 price target on the stock, up from their previous price target of $32.00.

Zoetis (NYSE:ZTS) had its hold rating reaffirmed by analysts at BMO Capital Markets. BMO Capital Markets currently has a $65.00 target price on the stock.

What are top analysts saying about Grupo Financiero Santander Mexico SA B de CV? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Grupo Financiero Santander Mexico SA B de CV and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit